|
|
|
|
Immunology trials often place a sustained burden on participants, where repeated travel to research sites becomes a major barrier that can delay recruitment, impact retention, and shape the overall study experience. MRN worked with a Sponsor to address this — integrating Home Trial Support (HTS) into a Phase 3 immunology trial. The result? 100% retention in the first 12 months — read on to learn how MRN achieved this and what the long-term retention results were.
|
|
|
|
|
Expanding access to clinical research requires more than identifying new sites. It calls for thoughtfully designed support models that make participation feasible for both patients and trial teams. Examine what this means and just how it important it is for enabling patient recruitment and retention as well as long-term sustainable partnerships with sites.
|
|
|
|
|
Get a greater understanding of how, when trials are designed around their participants and their families, the industry can deliver trials that are not only feasible but meaningful and, crucially, promote sustained enrollment, engagement and ultimately retention. DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens but also strengthening the family-researcher connection — fitting the trial around the family’s needs.
|
|
|
|
|
With 90% of clinical trials failing, soaring costs, and limited diversity, the traditional model is breaking down. Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency — reshaping clinical research into a more sustainable, inclusive future for patients and sponsors.
|
|
|
|
|
|
|
Don't miss us at SCOPE Florida this February! MRN will be attending and presenting with one of our industry partners (follow us on LinkedIn to find out who closer to the event). As global leaders in patient & community-centric Decentralized Clinical Trials (DCTs), this is your opportunity to meet in-person with the MRN Team and learn how we can increase enrollment and engagement and accelerate your trial timelines by bringing your trials to more patients in more communities. Schedule a meeting time here and visit us at Booth #1406.
|
|
|
